Abstract:
OBJECTIVE To analyze the influencing factors of pathogenic bacteria and lymphocyte reduction in patients with bloodstream infection.
METHODS The clinical data of 121 patients with bloodstream infection admitted to the first people’s hospital of Xining from Jan. 2016 to Jan. 2019 were retrospectively analyzed. According to the peripheral blood lymphocyte count on the day of blood culture, the patients were divided into 85 cases of lymphopenia group(lymphocyte <1.0×10
9 ) and 36 cases of control group(lymphocyte ≥1.0×10
9 ). The bacteria types and basic diseases of patients with bloodstream infection and lymphocyte reduction were compared to summarize the influencing factors of lymphocyte reduction in patients with bloodstream infection.
RESULTS The infection rate of
Enterococcus faecium 57.06%(6/85) and
Enterococcus faecalis 55.88%(5/85) in the lymphocytopenia group was significantly higher than that in the control group(
P=0.038 and
P=0.019, respectively). The proportion of patients with lymphocytopenia in which the underlying disease was tumor was significantly higher than that in the control group(
P<0.05). There was no significant difference in the proportion of other basic diseases between the two groups. Univariate analysis showed that age, C-reactive protein, procalcitonin(PCT), CD
3+T, CD
4+T, CD
8+ T, CD
4+/CD
8+T, the number of organs with incomplete function and tumor had certain influence of patients in the lymphocytopenia group and the control group(
P<0.05). The multivariate analysis results showed that young age and combined tumors were the influencing factors of lymphocyte reduction in patients with bloodstream infection.
CONCLUSION Patients with bloodstream infection were more likely to have decreased lymphocytes. The proportion of
E. faecalis and
E. faecalis infection in patients with decreased lymphocytes was higher. The basic diseases were mostly tumors, and young age and combined tumors were the influencing factors of lymphopenia in patients with bloodstream infection. Such patients should be closely monitored in clinical practice.